Trade Bolt Biotherapeutics, Inc. - BOLT CFD

Add to favourite

0.3884

2.95%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.0204

Long position overnight fee

-0.023485%

Short position overnight fee

0.001262%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.4002
Open	0.3984
1-Year Change	-69.98%
Day's Range	0.3791 - 0.3984

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Mar 31, 2025	0.4002	-0.0182	-4.35%	0.4184	0.4184	0.3983
Mar 28, 2025	0.4234	-0.0150	-3.42%	0.4384	0.4485	0.4234
Mar 27, 2025	0.4331	0.0047	1.10%	0.4284	0.4485	0.4284
Mar 26, 2025	0.4284	-0.0300	-6.54%	0.4584	0.4584	0.4284
Mar 25, 2025	0.4129	0.0001	0.02%	0.4128	0.4633	0.4128
Mar 24, 2025	0.4254	0.0260	6.51%	0.3994	0.4342	0.3994
Mar 21, 2025	0.4085	-0.0199	-4.65%	0.4284	0.4284	0.4003
Mar 20, 2025	0.4009	0.0025	0.63%	0.3984	0.4192	0.3884
Mar 19, 2025	0.4034	0.0030	0.75%	0.4004	0.4084	0.4004
Mar 18, 2025	0.4004	-0.0060	-1.48%	0.4064	0.4096	0.3944
Mar 17, 2025	0.4085	0.0091	2.28%	0.3994	0.4134	0.3994
Mar 14, 2025	0.4186	0.0172	4.29%	0.4014	0.4186	0.4014
Mar 13, 2025	0.4054	-0.0030	-0.73%	0.4084	0.4283	0.3984
Mar 12, 2025	0.4012	-0.0172	-4.11%	0.4184	0.4185	0.3984
Mar 11, 2025	0.4084	-0.0110	-2.62%	0.4194	0.4194	0.3984
Mar 10, 2025	0.4104	-0.0459	-10.06%	0.4563	0.4596	0.4097
Mar 7, 2025	0.4345	-0.0138	-3.08%	0.4483	0.4484	0.4184
Mar 6, 2025	0.4484	-0.0039	-0.86%	0.4523	0.4574	0.4414
Mar 5, 2025	0.4434	-0.0038	-0.85%	0.4472	0.4493	0.4384
Mar 4, 2025	0.4406	-0.0071	-1.59%	0.4477	0.4548	0.4301

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Bolt Biotherapeutics, Inc. Company profile

About Bolt Biotherapeutics Inc

Bolt Biotherapeutics, Inc is a clinical-stage immuno-oncology company. The Company is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Its Immune-Stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells, including macrophages and dendritic cells, that kill tumor cells via phagocytosis and expose tumor neoantigens to the adaptive immune system. The Company’s product candidate BDC-1001 is a human epidermal growth factor receptor 2 (HER2) Boltbody ISAC comprised of a HER2-targeting biosimilar, of trastuzumab conjugated to one of its TLR7/8 agonists, for the treatment of patients with HER2-expressing solid tumors, including those with HER2-low tumors. Its Toll-like receptors (TLRs) activate myeloid cells and enable the presentation of tumor-associated neoantigens to cytotoxic T cells.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Bolt Biotherapeutics Inc revenues increased from $231K to $752K. Net loss increased from $29.7M to $71.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and d increase of 99% to $49.8M (expense), Fair Value Adjustments on Other Assets decrease from $2.4M (income) to $6.1M (expense).

Industry:

Bio Therapeutic Drugs

900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US